John Kelley Chairman of CereScan

CereScan Corp., a Denver-based provider of high-definition functional brain imaging, today announced that John A. Kelley joined CereScan’s Board as both a member and as Chairman.

Mr. Kelley brings CereScan over 20 years of senior executive experience including serving as the Chairman of the Board of Directors, President and Chief Executive Officer of McDATA Corporation, a worldwide leader in open storage networking solutions. Mr. Kelley grew McDATA Corporation’s annual revenues from $200 million to $630 million before its sale to Brocade Communications Systems, Inc. in January 2007 for over $1 billion. Prior to joining McDATA, Mr. Kelley served as Executive Vice President of Networks at Qwest Communications after serving as President of Wholesale Markets and Federal Services for U.S. West. Previously, he was Area President for Mead Corporation’s Zellerbach Southwest Business Unit and held senior positions at Xerox and NBI. Mr. Kelley received a Bachelor of Science degree in business from the University of Missouri, St. Louis. He serves on the board of directors of Polycom, Inc., is a member of the Rocky Mountain INROADS Board, a not-for-profit mentoring program, and a board member of the Women’s Vision Foundation and Tie-Rockies.

Mr. Kelley stated: "My decision to join CereScan was predicated upon the exciting opportunities presented by the emerging medical, legal and military applications developed by CereScan. I am enthusiastically looking forward to working with CereScan’s team of professionals to build out a national network of state of the art brain scanning imaging centers."

Commenting on Mr. Kelley’s appointment, Gary J. Graham, the President of First Capital Business Development, LLC, CereScan’s business advisor, said: "That CereScan was able to attract a successful and experienced executive with John’s leadership skills is a testimonial to the viability of CereScan’s advanced diagnostic imaging applications. These include a proprietary 3,000 patient scan database, and imaging protocols focused on a variety of brain disorders, such as Toxic Brain Injury, Obsessive Compulsive Disorder, ADHD, Depression, Anxiety Disorder, Bipolar Disorder and Alzheimer’s Disease. We can detect Alzheimer’s Disease five to seven years prior to the onset of symptoms."